Join us on May 28th in celebration of International Day of Action for Women’s Health, as the Medpace Women’s Health Leadership Team explores the dynamic landscape of Women’s Health clinical development.
Aparna Shah, MD, FACOG, Rujin Ju, MD, MSCR, FACOG, and Beth Tulip, Senior Executive Director of Clinical Trial Management, discuss key medical and operational insights as it relates to Women’s Health clinical development in our upcoming panel. Register now!
Expert Panelists:
The Evolving Women’s Health Clinical Development Landscape
May is recognized as National Women’s Health Awareness Month, highlighting the unique challenges and disparities in healthcare that women face globally. Despite comprising around half of the world’s population, women have historically been understudied and underrepresented in clinical research, leading to significant gaps in knowledge and treatment options. However, amidst the recent biotech slowdown, Women’s Health clinical development is garnering increasing attention in recent years. Venture capital funding for Women’s Health is increasing, driven by FDA and White House initiatives focused on Women’s Health research.
Our panel of experts will explore the past, present, and future of Women’s Health clinical research, addressing common misconceptions and highlighting significant opportunities for investment and innovation. Our discussion will span the entire spectrum of women’s health needs across the life cycle, ranging from adolescent to post-menopausal gynecologic needs.
Medpace’s Women’s Health Leadership team will share key insights into the unique medical and operational aspects of Women’s Health clinical development. From study design and site selection to recruitment, retention, and operational strategies, our discussion will equip biopharmaceutical companies with actionable insights to drive impactful research outcomes.
Don’t miss the opportunity to gain expert guidance and contribute to the advancement of Women’s Health clinical development on a global scale. Register now to secure your place and join us in shaping the future of healthcare for women worldwide.
Accelerating Global Women’s Health Clinical Development
When you partner with Women’s Health CRO Medpace, medical leadership is fully embedded within the clinical trial process from inception to completion to help accelerate development. Your trial will benefit from our in-depth knowledge of disease processes and pathophysiology unique to women, relevant outcome measures, and standards of care.
Medpace medical leadership and expertise in Women’s Health spans multiple therapeutic areas and indications, including Gynecology, Urogynecology, Oncology, Endocrinology and Metabolic Disease, and Infectious Disease and Vaccines (ID&V).